Riposte Capital »

Indivior Pharmaceuticals shares owned by Riposte Capital

Quarter-by-quarter ownership of Indivior Pharmaceuticals (INDV) shares owned by Riposte Capital from 13F filings

Historical chart of Riposte Capital investment in Indivior Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Indivior Pharmaceuticals held by Riposte Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Indivior Pharmaceuticals by Riposte Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.1M 200k 30.48

More positions owned by Riposte Capital

Spdr S&p 500 Etf Tr Put Put Option
Ishares Tr Put Put Option
MasTec (MTZ)
Birkenstock Holding Com Shs
Qxo Com New
Barrick Mng Corp Com Shs (B)
Citizens Put Put Option
Micron Technology (MU)
Coherent Corp (COHR)
Turning Pt Brands (TPB)
Lam Research Corp Com New (LRCX)
On Hldg Namen Akt A (ONON)
Corning Incorporated (GLW)
Uber Technologies (UBER)
Highpeak Energy Put Put Option

View all positions for Riposte Capital

Top funds holding Indivior Pharmaceuticals

BlackRock
Vanguard Portfolio Management
Oaktree Capital Management
Vanguard Capital Management
State Street Corporation
Two Seas Capital
Millennium Management
Hanna Zanoni
Madison Avenue Partners
Citadel Advisors
Morgan Stanley
Deerfield Management Company
Geode Capital Management
Mangrove Partners
Goldman Sachs Group

View all funds holding Indivior Pharmaceuticals